CRP and neoplasm: The majority of the previous studies presumed that elevated serum CRP levels in patients with malignancy were probably a bodily response, secondary to tumor necrosis, local tissue damage and associated inflammation through the cytokines released from leukocytes infiltrating within the tumor microenvironment, in particular IL-6 (31).